BioCentury
ARTICLE | Company News

Ajinomoto Pharmaceuticals Co. Ltd., Eisai, Takeda sales and marketing update

March 11, 2013 7:00 AM UTC

Ajinomoto and Eisai announced the launch of once-monthly 75 mg Actonel/ Benet risedronate in Japan to treat osteoporosis. Japan's National Health Insurance (NHI) listed the antiresorptive pyridinyl b...